About the Authors

Sabrina Kneissl

Sabrina.Kneissl@pei.de (SK); Christian.Buchholz@pei.de (CJB)

Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

Tobias Abel

Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

Anke Rasbach

Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

Julia Brynza

Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

Jürgen Schneider-Schaulies

Affiliation Institute of Virology and Immunobiology, University of Würzburg, Würzburg, Germany

Christian J. Buchholz

Sabrina.Kneissl@pei.de (SK); Christian.Buchholz@pei.de (CJB)

Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

Competing Interests

SK and CJB are listed as inventors in an international Patent Cooperation Treaty/European patent application (PCT/EP2007/008384 “Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening”) assigned to the Paul-Ehrlich-Institut, which includes as claims the generation of targeted lentiviral vectors. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: SK CJB. Performed the experiments: SK TA JB. Analyzed the data: SK TA AR CJB. Contributed reagents/materials/analysis tools: JS-S. Wrote the paper: SK CJB.